Current immunosuppressive treatment after kidney transplantation. - Wikidata - awgldk - TriplyDB

Current immunosuppressive treatment after kidney transplantation.

Current immunosuppressive treatment after kidney transplantation.

http://www.wikidata.org/entity/Q37834028

about

New molecular medicine-based scar management strategies Infection-related hospitalizations over 30 years of follow-up in patients starting renal replacement therapy at pediatric age.Use of an anti-CD200 antibody for prolonging the survival of allografts: a patent evaluation of WO2012106634A1.The application of RNAi-based treatments for inflammatory bowel disease.Dosing algorithms for initiation of immunosuppressive drugs in solid organ transplant recipients.Interferon-Gamma DNA Methylation Is Affected by Mycophenolic Acid but Not by Tacrolimus after T-Cell Activation.A comprehensive characterization of the impact of mycophenolic acid on the metabolism of Jurkat T cells.Biomarkers in solid organ transplantation.

P2860

Q33560989-CF142505-968F-4AF7-95A0-485C2480963A Q36400328-75E3974D-91F1-48EF-8399-3C76BEA11992 Q38076768-32E9DC8A-A653-480D-A715-D8DBB3714F1C Q38382964-BBF35EC5-3DFE-49E9-BEA4-6874F42320F9 Q38417581-3407BCBF-1502-467D-8657-67E56379C9F6 Q40987197-C31BE44E-E9ED-4E77-8B8B-2B05E292F02C Q41620097-0C63795E-6AB5-47B9-85BB-345A6833CA87 Q50207743-CA727A3F-1CA0-4E34-8741-2BA53C0A8ECD

P2860

Current immunosuppressive treatment after kidney transplantation.

http://www.wikidata.org/entity/Q37834028

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 02 February 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Current immunosuppressive treatment after kidney transplantation.

@en

Current immunosuppressive treatment after kidney transplantation.

@nl

type

label

Current immunosuppressive treatment after kidney transplantation.

@en

Current immunosuppressive treatment after kidney transplantation.

@nl

prefLabel

Current immunosuppressive treatment after kidney transplantation.

@en

Current immunosuppressive treatment after kidney transplantation.

@nl

P1433

Q37834028-E9A0383D-8AC5-4C35-B844-5D1C4FA4312A

P1476

Q37834028-BE5E7412-01B7-43F3-A9E0-1C1983488B11

P2093

Q37834028-28ABAE9A-0B1F-46DA-BE58-AE59CB03813D

Q37834028-94C70D32-455D-4A89-83AE-56B96725DA0F

Q37834028-B4A06B63-0239-406E-AF3D-35434ED24868

P2860

Q37834028-035B3F59-57E6-4966-8C33-D5F3DE0EB76A

Q37834028-059CBCE3-6BF1-4C64-831A-1999D2DE86ED

Q37834028-06DB84D8-0225-4D71-ADA4-305E3A111622

Q37834028-0DD80D68-A94A-4EEA-802C-E0C95FA6C9C4

Q37834028-0E81203D-6BCD-45FC-A331-4F09A7B8B240

Q37834028-1034D692-B780-4BC6-AF2E-D4C3C9D95490

Q37834028-121B4CE5-4C1A-4768-A94A-D6732C648787

Q37834028-1374FBEA-B47D-4B78-87D1-CCA1380B7E9F

Q37834028-168F72BA-C2FD-4523-A192-D64A8C7FB8CF

Q37834028-1BFF3443-DDCF-4B7F-8B94-516A499E85EB

P304

Q37834028-52CDB807-6D8F-4C5B-A7D7-B81EC8493477

P31

Q37834028-57896327-09F5-41C4-BFEE-89C6030232C7

P356

Q37834028-E9416BC8-9B8C-4C89-9523-EEA60C1DA31B

P407

Q37834028-36315AD2-7F80-4089-B006-6D6CD0E61EB4

P433

Q37834028-6443C2D2-5008-449A-8371-46D889C0198B

P478

Q37834028-2D44681B-9B27-4F6A-89A1-828E1794AD81

P50

Q37834028-BBDF47AC-946B-4559-8DD6-972837F4552F

P577

Q37834028-A4F292D4-C0AE-49A0-A79F-301942331BA7

P698

Q37834028-6AD92C31-A4A2-4E8D-BD5E-C8127A238C7D

P356

14656566.2011.552428

P1433

Expert Opinion on Pharmacotherapy

P1476

Current immunosuppressive treatment after kidney transplantation.

@en

P2093

Karlien Cransberg

http://www.w3.org/2001/XMLSchema#string

Marcia Kho

http://www.w3.org/2001/XMLSchema#string

Teun van Gelder

http://www.w3.org/2001/XMLSchema#string

P2860

The use of antibody to complement protein C5 for salvage treatment of severe antibody-mediated rejection

Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data

A worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts.

The effect of antilymphocyte induction therapy on renal allograft survival. A meta-analysis of individual patient-level data. Anti-Lymphocyte Antibody Induction Therapy Study Group.

Long-term improvement in renal function with sirolimus after early cyclosporine withdrawal in renal transplant recipients: 2-year results of the Rapamune Maintenance Regimen Study.

Bortezomib provides effective therapy for antibody- and cell-mediated acute rejection.

Abrogation of anti-HLA antibodies via proteasome inhibition.

Steroid avoidance or withdrawal after renal transplantation increases the risk of acute rejection but decreases cardiovascular risk. A meta-analysis.

B-cell-depleting induction therapy and acute cellular rejection

Rabbit antithymocyte globulin versus basiliximab in renal transplantation.

P304

1217-1231

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14656566.2011.552428

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-02-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21284571

http://www.w3.org/2001/XMLSchema#string